The Effect of Tramadol on Interscalene Brachial Plexus Block

The Effect of Tramadol on Interscalene Brachial Plexus Block With Ropivacaine in Shoulder Surgery.

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02182752

Enrollment

Registered

2014-07-08

Start date

2013-04-30

Completion date

Unknown

Last updated

2016-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Injury, Shoulder Arthritis, Shoulder Dislocation, Shoulder Fracture

Brief summary

The purpose of our study is to evaluate the effect of tramadol as an adjunct to ropivacaine local anesthetic solution in interscalene brachial plexus block for shoulder surgery.

Interventions

DRUGRopivacaine - Tramadol

Interscalene block using ropivacaine plus tramadol

DRUGRopivacaine

Interscalene block using ropivacaine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 79 Years

Healthy volunteers

Inclusion criteria

* Shoulder surgery

Exclusion criteria

* patients on opioids * diabetes mellitus * interscalene block contraindicated * patient refusing regional anesthesia techniques

Design outcomes

Primary

Measure	Time frame
Postoperative analgesia	24 hours postoperatively

Secondary

Measure	Time frame
Persistent postoperative pain	1 month postoperatively, 3 months postoperatively
Evidence of motor blockade resolution, confirmed by elbow - wrist - fingers active movement	24 hours postoperatively
Evidence of sensory blockade resolution, confirmed by pin-prick test	24 hours postoperatively

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026